Volpara Health Technologies (ASX:VHT) reports excellent results in 2nd round in breast cancer screening

Volpara Health Technologies (ASX:VHT) reports excellent results in 2nd round in breast cancer screening

[videojs_hls url=’//du7x25at22z7c.cloudfront.net/328136/index_HLSv3.m3u8′ poster=’http://www.finnewsnetwork.com.au/newssystem/2021/Headlines04_360_210318.jpg’]

 

Health software company Volpara Health Technologies (ASX:VHT) reports their trial in breast cancer screening had excellent results in the second-round.

The study used Volpara®Density™ software to assess breast density. The results showed a significant reduction in interval cancers in those women being selected for breast MRI. False-positive rate significantly reduced relative to first results two years ago.

Shares in Volpara Health Technologies (ASX:VHT) are trading 2.3 per cent higher at $1.32.

Copyright 2021 – Finance News Network


Source: Finance News Network

Share this post